Aizen Therapeutics
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $9.4M
Investors
- 3
About Aizen Therapeutics
Founded in 2022 by Ajay Kshatriya, Todd Peterson, and David Van Valen, and based in California, US, Aizen Therapeutics is a biotechnology that develops medicine for treating solid tumors and neuroscience. Aizen Therapeutics focuses on creating Mirror Peptides, which are synthetic peptides made entirely from D-amino acids. These peptides provide improved stability and reduced immunogenicity compared to traditional therapies. Utilizing the proprietary DaX™ platform, the company designs and optimizes these peptides for targeted delivery, serving pharmaceutical firms and research institutions primarily in North America and Europe. Aizen Therapeutics generates revenue through partnerships and collaborations with pharmaceutical and biotechnology firms, including licensing agreements for its Mirror Peptides and DaX™ platform. The company aims to launch innovative products utilizing its advanced peptide technology and plans to expand its market presence in Europe and Asia by 2025, targeting increased demand for next-generation therapeutics.
Who invested in Aizen Therapeutics
3 investors across 1 round
See all investors in Aizen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 21, 2024
Amount
$9.4M
Investors
Questions about Aizen Therapeutics
Who invested in Aizen Therapeutics?
Aizen Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aizen Therapeutics raised?
Aizen Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aizen Therapeutics last raise money?
Aizen Therapeutics's most recent round on record is a Seed, in Nov 2024.
What does Aizen Therapeutics do?
Founded in 2022 by Ajay Kshatriya, Todd Peterson, and David Van Valen, and based in California, US, Aizen Therapeutics is a biotechnology that develops medicine for treating solid tumors and neuroscience.
Where is Aizen Therapeutics headquartered?
Aizen Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Aizen Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aizen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Aizen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.